112 related articles for article (PubMed ID: 18838912)
1. (18) F-FDG PET imaging of rheumatoid articular and extraarticular synovitis.
Fonseca A; Wagner J; Yamaga LI; Osawa A; da Cunha ML; Scheinberg M
J Clin Rheumatol; 2008 Oct; 14(5):307. PubMed ID: 18838912
[No Abstract] [Full Text] [Related]
2. (18)F-FDG-PET assessment of early treatment response of articular and extra-articular foci in newly diagnosed rheumatoid arthritis.
Sarma M; Vijayant V; Basu S
Hell J Nucl Med; 2012; 15(1):70-1. PubMed ID: 22413120
[No Abstract] [Full Text] [Related]
3. F-18 FDG whole-body PET for the assessment of disease activity in patients with rheumatoid arthritis.
Goerres GW; Forster A; Uebelhart D; Seifert B; Treyer V; Michel B; von Schulthess GK; Kaim AH
Clin Nucl Med; 2006 Jul; 31(7):386-90. PubMed ID: 16785804
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET as a tool to predict the clinical outcome of infliximab treatment of rheumatoid arthritis: an explorative study.
Elzinga EH; van der Laken CJ; Comans EF; Boellaard R; Hoekstra OS; Dijkmans BA; Lammertsma AA; Voskuyl AE
J Nucl Med; 2011 Jan; 52(1):77-80. PubMed ID: 21149486
[TBL] [Abstract][Full Text] [Related]
5. (18)F-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3.
Beckers C; Jeukens X; Ribbens C; André B; Marcelis S; Leclercq P; Kaiser MJ; Foidart J; Hustinx R; Malaise MG
Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):275-80. PubMed ID: 16247604
[TBL] [Abstract][Full Text] [Related]
6. 18F-FDG PET in rheumatoid arthritis: there still is a long way to go.
Brenner W
J Nucl Med; 2004 Jun; 45(6):927-9. PubMed ID: 15181125
[No Abstract] [Full Text] [Related]
7. Delay in imaging versus clinical response: a rationale for prolonged treatment with anti-tumor necrosis factor medication in early rheumatoid arthritis.
Wakefield RJ; Freeston JE; Hensor EM; Bryer D; Quinn MA; Emery P
Arthritis Rheum; 2007 Dec; 57(8):1564-7. PubMed ID: 18050231
[No Abstract] [Full Text] [Related]
8. Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET.
Beckers C; Ribbens C; André B; Marcelis S; Kaye O; Mathy L; Kaiser MJ; Hustinx R; Foidart J; Malaise MG
J Nucl Med; 2004 Jun; 45(6):956-64. PubMed ID: 15181130
[TBL] [Abstract][Full Text] [Related]
9. Anti-TNF scintigraphy to assess TNF-α-associated joint inflammation in rheumatoid arthritis and osteoarthritis.
Hermann J; Lipp RW; Dunzinger A; Spreizer C; Schaffler G; Kvaternik H; Ofner P; Graninger W
Clin Exp Rheumatol; 2014; 32(4):614. PubMed ID: 24959905
[No Abstract] [Full Text] [Related]
10. Doppler ultrasound measurements of knee joint synovitis in rheumatoid arthritis patients treated with infliximab.
Kasukawa R; Shio K; Kanno Y; Sato A; Takahashi A; Yamadera Y; Kanno T
Mod Rheumatol; 2007; 17(5):376-9. PubMed ID: 17929128
[TBL] [Abstract][Full Text] [Related]
11. High-resolution (18)F-FDG PET/CT for assessing disease activity in rheumatoid and psoriatic arthritis: findings of a prospective pilot study.
Chaudhari AJ; Ferrero A; Godinez F; Yang K; Shelton DK; Hunter JC; Naguwa SM; Boone JM; Raychaudhuri SP; Badawi RD
Br J Radiol; 2016 Jul; 89(1063):20160138. PubMed ID: 27109738
[TBL] [Abstract][Full Text] [Related]
12. Visualization and localization of rheumatoid knee synovitis with FDG-PET/CT images.
Ju JH; Kang KY; Kim IJ; Yoon JU; Kim HS; Park SH; Kim HY
Clin Rheumatol; 2008 Dec; 27 Suppl 2():S39-41. PubMed ID: 18369527
[TBL] [Abstract][Full Text] [Related]
13. [Positron emission tomography with (18)F-FDG in the evaluation of patients with rheumatoid arthritis--a systematic review].
dos Anjos DA; da Mota LM
Rev Bras Reumatol; 2014; 54(6):474-82. PubMed ID: 25458029
[TBL] [Abstract][Full Text] [Related]
14. Advances in positron emission tomography for the imaging of rheumatoid arthritis.
Narayan N; Owen DR; Taylor PC
Rheumatology (Oxford); 2017 Nov; 56(11):1837-1846. PubMed ID: 28181650
[TBL] [Abstract][Full Text] [Related]
15. F-18 fluorodeoxyglucose positron emission tomography can detect early response to adalimumab, a tumor necrosis factor-α antagonist, in rheumatoid arthritis: A prospective pilot study.
Edupuganti SR; Eder V; Ternant D; Courtehoux M; Tranquart F; Goupille P; Paintaud G; Mulleman D
Joint Bone Spine; 2015 Oct; 82(5):381-3. PubMed ID: 25776440
[No Abstract] [Full Text] [Related]
16. Clinical images: infliximab therapy of polyarticular small joint sarcoid arthritis.
Huang A; Harty LC; Ryan CM; Veale DJ
Arthritis Rheum; 2011 Jul; 63(7):2030. PubMed ID: 21425127
[No Abstract] [Full Text] [Related]
17. Rheumatoid hand joint synovitis: gray-scale and power Doppler US quantifications following anti-tumor necrosis factor-alpha treatment: pilot study.
Ribbens C; André B; Marcelis S; Kaye O; Mathy L; Bonnet V; Beckers C; Malaise MG
Radiology; 2003 Nov; 229(2):562-9. PubMed ID: 12970463
[TBL] [Abstract][Full Text] [Related]
18. Macrophage positron emission tomography imaging as a biomarker for preclinical rheumatoid arthritis: findings of a prospective pilot study.
Gent YY; Voskuyl AE; Kloet RW; van Schaardenburg D; Hoekstra OS; Dijkmans BA; Lammertsma AA; van der Laken CJ
Arthritis Rheum; 2012 Jan; 64(1):62-6. PubMed ID: 21898356
[TBL] [Abstract][Full Text] [Related]
19. Radiographic benefit without clinical improvement in infliximab-treated patients with rheumatoid arthritis: comment on the article by Smolen et al.
Pincus T; Yazici Y; Yazici H; Kavanaugh AF; Kremer JM; Wolfe F
Arthritis Rheum; 2005 Dec; 52(12):4044-5; author reply 4045-7. PubMed ID: 16320353
[No Abstract] [Full Text] [Related]
20. Tuberculous synovitis of the hip joint diagnosed by FDG PET-CT.
Makis W; Abikhzer G; Stern J
Clin Nucl Med; 2009 Jul; 34(7):431-2. PubMed ID: 19542947
[No Abstract] [Full Text] [Related]
[Next] [New Search]
